- Hopeful Sign: If Selloff Stays Shallow
- Pitting Wall Street vs Auto Makers: Is It Fair?
- Europe Banks in Huge Rate Cuts; U.S. Earnings Glum
- Winner Today? Home Builder Stocks
- Exxon's Amazing Stat: Market Cap Of $400 Billion
- So, One Government Rescue Program Working?
- A Bottom Or Not? Pick Your Analyst
- There's No Sign Of A Bottom Yet
- Traders "Betting" Big 3 Get Bailout Money
- "Volatility Trade" Biggest Factor In Sell-Off?
- How to Move Forward After a Layoff, Part 2
- Jobs Numbers: Breakdown by Sector
- Congress And Automakers: Long And Difficult "Marriage" Ahead
- Great Companies Come at Fair Prices
- Yoshikami: Investing & the Obama Presidency
- Wall of Shame: Fortress Investment's Wes Edens
- Cramer to Geithner: Let FDIC Chair Keep Her Job
- Lightning Round: Boeing, Medtronic, Agrium and More
- Lightning Round OT: Continental, Amylin Pharma and More
- Economy Sheds 533,000 Jobs, Most in 34 Years
- Citigroup Sells German Arm for $6.7 Billion
- Charts Predict S&P Festive Rally Above 1,000
- BMW's Global Sales Plunge by a Quarter in Nov.
- What the Pros Say: S&P May Fall to 700
- Bleak Jobs Data Forecasts Add to Automakers' Woes
- Euro Shares Extend Fall after US Jobs Data
- European Stocks to Open Sharply Lower
- Toshiba to Briefly Halt Chip Output on Weak Demand
More Videos
Text Size 
This was a day that started out with inflation as the new global concern:
--ECB hawkish
--Fed talking tough on inflation
--Bank of Canada did not ease, when it was expected to do so
--Inflation worries roil Vietnam, that country's stock market hits a two-year low; China's Shanghai index also hits a new low
The dollar rallied as the Fed talked tough on inflation. That hurt commodity stocks like energy and materials. Financials, which have been down 5 days in a row, staged a modest but unenthusiastic rally. Big pharmaceutical stocks like Merck[MRK
Loading...
()
], Pfizer, Sanofi,[SNY
Loading...
()
] and Bristol Meyers[BMY
Loading...
()
] hit new lows, as the world has now discovered that these are no longer safe, defensive plays.
Everyone talking about Pfizer's [PFE
Loading...
()
] huge 7.1 percent dividend yield, which gets bigger every day because the stock keeps dropping. Is it safe? The $1.28 a share dividend liability costs them about $9 billion a year; even with Lipitor going off patent in 2010, Deutsche Bank estimates they will still generate $14 b in cash flow, enough to fund the dividend, even if they have to repatriate some of the sizeable amounts of cash that are parked overseas.
But let's face it folks. There are a lot of people who own Pfizer just for the dividend, and the stock is trading like they are going to cut the dividend, cash flow or not.
related content |
Questions? Comments?
Del.icio.us
Digg It
Data is a real-time snapshot *Data is delayed at least 15 minutes